SREBF1 and Insulin resistance: demonstrated that tacrolimus caused hepatic insulin resistance and triglyceride accumulation through insulin receptor substrate (IRS)2/AKT and sterol regulatory element binding protein (SREBP1) signaling, and respectively via CREB‐regulated transcription coactivator 2 (CRTC2) in mice.23